interleukin-17 (Immunex)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinterleukin-17 (Immunex)
Drug Alias NameIL-17 (Immunex)IL-17
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin-17 agonists
TargetsInterleukin-17
Therapy Area/IndicationsBone Marrow Failure DisordersCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunex Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunex Corp
Active IndicationsN/A
Inactive IndicationsBone Marrow Failure DisordersCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A